By
AmyT on
April 22, 2013
Two weeks ago today for Spring Break I was in gorgeous, palm-studded Santa Barbara, CA. And what does a diabetes technology geek like me do on vacation? Visit the local research clinic, of course!
Lucky for me, the Sansum Diabetes Research Institute in Santa Barbara (home to the legendary Drs. Lois Jovanovic and Howard Zisser) just happened to be running a clinical trial they were calling “Party Study 2.” I am not making this up.…
Read more »
By
AmyT on
March 13, 2013
Neal Kaufman is not only the husband of famed endocrinologist and Medtronic exec Fran Kaufman; he’s also a diabetes guru of sorts in his own right. He’s an experienced clinician and educator who founded a company called DPS Health (Diabetes Prevention Source), that offers an intense coaching program using technology + real-life interventions to help people with pre-diabetes and type 2 diabetes improve their lifestyles. Like us, he’s extremely interested in all sorts of D-technologies…
Read more »
Finding a less invasive method of taking insulin seems to be all the rage these days. Although the once-hailed Exhubera fizzled away, researchers have not given up on the “holy grail” of oral insulin. Aside from Mannkind’s Afrezza, which is delayed and controversial, there’s another kind of oral insulin that might be making its mark in the diabetes marketplace… eventually.
Meet MonoSol Rx.
This New Jersey-based company has created PharmFilm, a thin, postage-sized film that…
Read more »
Last week, the New York Chapter of the Juvenile Diabetes Research Foundation hosted their annual research briefing. Many chapters around the country host similar research briefings, and I was excited to find out that our local meeting would feature Dr. Sanjoy Dutta, Director of Glucose Control Therapies within the Treatment Therapies Program.
I want to note that although there’s been a lot of controversy surrounding the addition of treatment goals to JDRF’s mission, I whole-heatedly…
Read more »
By
AmyT on
January 24, 2011
I can’t help it. This reminds me of the movie City Slickers, in which one of the characters has messed up his life, and his friends tell him he’s getting a “do-over.” The young company Dance Pharmaceuticals, based in downtown San Francisco, is basically on a mission to salvage the good parts of Pfizer’s failed inhaled insulin Exubera (not the awkward delivery device!) and launch a second coming of the base product that is “simpler,…
Read more »
